Afaxys Announces Leadership Evolution to Accelerate Growth and Public Health Impact
CHARLESTON, S.C., March 26, 2025 – Afaxys, Inc., a Public Benefit Corporation and first-of-its kind socially conscious healthcare company focused on serving public health professionals and their patients, today announced an evolution of its leadership structure designed to amplify its impact on public health and drive sustainable growth. Ronda Dean, who has served as both President & Chief Executive Officer (CEO) of Afaxys, will continue as CEO, while Christian Bloomgren has been promoted to President & Chief Commercial Officer (CCO).
This strategic appointment establishes two distinct leadership roles to address both internal and external business priorities, with the overarching goal of expanding access to sexual and reproductive healthcare for patients within the public health system. In his expanded role, Christian will ensure seamless execution and operational excellence at Afaxys. Meanwhile, Ronda will focus on investor and external relationships, enhancing Afaxys’ presence and impact across the broader healthcare landscape.
“This leadership transformation reflects the next step in our evolution as an organization,” said Ronda Dean, CEO & Co-Founder of Afaxys. “By clearly defining these critical roles, we are strengthening our foundation, streamlining operations and positioning Afaxys for continued success. Christian’s deep industry expertise, strategic vision and proven track record as CCO make him the ideal leader to continue driving our operational excellence.”
Christian Bloomgren, President & CCO, added, “I’m honored to take on this expanded role during such a pivotal time for our company and stakeholders. Our mission remains unchanged – ensuring access to healthcare for those who need it most. I look forward to working with our team to drive meaningful impact and strengthen our future.”
About Afaxys
Afaxys, Inc., a Public Benefit Corporation, uniquely partners with public health and private industry to ensure healthcare professionals have stable pricing and reliable access to the products and services they need to care for their patients, contributing to a healthier and more empowered society.
The Afaxys enterprise comprises a family of companies that operate under four wholly owned subsidiaries: Afaxys Pharma, LLC, Afaxys Group Services, LLC (AGS), Afaxys Drug Development, LLC and Afaxys Marketplace, LLC.
Forward-Looking Statements
The statements in this press release that are not historical facts constitute “forward-looking statements” as defined by Federal Securities laws. Such statements are subject to risks and uncertainties that could cause actual results to differ materially from future results expressed or implied by such forward-looking statements. Potential risks and uncertainties include, but are not limited to, risks related to the inability to implement strategic initiatives, and the dependence on key personnel. Forward-looking statements speak only as of the date they are made. Afaxys, Inc. will not update forward-looking statements to reflect factual assumptions, circumstances or events that have changed after a forward-looking statement was made.
Afaxys Media Contact
Green Room Communications
gr_afaxys@grcomms.com